The 4th Frankfurt Conference on Quality Control in Life Processes welcomed more than 300 speakers and attendees from all over the world....

A new computational drug design challenge is being launched from our PROXIDRUGS partner Merck KGaA: the Proximity-Inducing Drugs...

Targeted protein degradation (TPD) is an emerging therapeutic strategy that hijacks the cellular recycling machinery to degrade and...

On November 18th and 19th present and new industry and academic partners came together for the annual PROXIDRUGS retreat to discuss...

With Ivan Đikić and Gerhard Hummer two PROXIDRUGS Project Leaders are recognized as Highly Cited Researchers in their fields on...

In a study published in today’s issue of Science, a team around PROXIDRUGS speaker Ivan Đikić reveals how cells deploy ubiquitination and...

The PROXIDRUGS Innovation Management team, together with PROXIDRUGS partners Paul Gehrtz , Principal Scientist MedChem at Merck Gruppe ...

PROXIDRUGS speaker Ivan Đikić has been awarded a prestigious LOEWE-Spitzenprofessur at Goethe University Frankfurt. The Hessian LOEWE...

The PROXIDRUGS consortium was successfully evaluated by an independent jury and will be funded by the Federal Ministry of Education and...

In their latest publication in Chemistry, PROXIDRUGS project leader Felix Hausch and colleagues present the design of ultrapotent FKBP...